File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Public fertility preservation programme for cancer patients in Hong Kong

TitlePublic fertility preservation programme for cancer patients in Hong Kong
Authors
Issue Date17-Dec-2024
PublisherHong Kong Academy of Medicine
Citation
Hong Kong Medical Journal, 2024, v. 30, n. 6, p. 452-460 How to Cite?
Abstract

Introduction: Fertility preservation (FP) offers cancer patients the opportunity to have biological children after completing treatment. This study was performed to review the experience and changes in service demand since the implementation of a public FP programme for cancer patients in Hong Kong. Methods: This retrospective study included men and women who attended an assisted reproduction unit for public FP services before cancer treatment from August 2020 to February 2023. Their medical records were reviewed and the results were compared with findings from our previous study to evaluate trends in service demand. Results: During the study period, there were 48 consultations for female FP, compared with 72 women who presented for FP from 2010 to 2020 prior to establishment of the public FP programme. The median time from referral to consultation was 3 days (interquartile range [IQR]=2-5). Eighteen women (37.5%) underwent 19 cycles of ovarian stimulation for oocyte or embryo cryopreservation. Thirty women (62.5%) received gonadotropin-releasing hormone agonists during cancer treatment. There were 58 consultations for male FP during the study period, compared with 265 men who presented for sperm cryopreservation from 2005 to 2020. The median time from referral to consultation was 4 days (IQR=2-7). Fifty-five men (94.8%) attempted sperm cryopreservation, and 49 (84.5%) successfully preserved sperm. Conclusion: Since the establishment of a public FP programme for cancer patients, there has been an increase in the demand for FP services at our centre. Regular review of FP services is warranted to assess changes in demand and identify areas for improvement. 


Persistent Identifierhttp://hdl.handle.net/10722/353490
ISSN
2023 Impact Factor: 3.1
2023 SCImago Journal Rankings: 0.261

 

DC FieldValueLanguage
dc.contributor.authorChan, Dorothy TY-
dc.contributor.authorKo, Jennifer KY-
dc.contributor.authorLam, Kevin KW-
dc.contributor.authorTong, Yu Wing-
dc.contributor.authorWong, Evelyn-
dc.contributor.authorCheng, Heidi HY-
dc.contributor.authorYung, Sofie SF-
dc.contributor.authorLi, Raymond HW-
dc.contributor.authorNg, Ernest HY-
dc.date.accessioned2025-01-18T00:35:24Z-
dc.date.available2025-01-18T00:35:24Z-
dc.date.issued2024-12-17-
dc.identifier.citationHong Kong Medical Journal, 2024, v. 30, n. 6, p. 452-460-
dc.identifier.issn1024-2708-
dc.identifier.urihttp://hdl.handle.net/10722/353490-
dc.description.abstract<p>Introduction: Fertility preservation (FP) offers cancer patients the opportunity to have biological children after completing treatment. This study was performed to review the experience and changes in service demand since the implementation of a public FP programme for cancer patients in Hong Kong. Methods: This retrospective study included men and women who attended an assisted reproduction unit for public FP services before cancer treatment from August 2020 to February 2023. Their medical records were reviewed and the results were compared with findings from our previous study to evaluate trends in service demand. Results: During the study period, there were 48 consultations for female FP, compared with 72 women who presented for FP from 2010 to 2020 prior to establishment of the public FP programme. The median time from referral to consultation was 3 days (interquartile range [IQR]=2-5). Eighteen women (37.5%) underwent 19 cycles of ovarian stimulation for oocyte or embryo cryopreservation. Thirty women (62.5%) received gonadotropin-releasing hormone agonists during cancer treatment. There were 58 consultations for male FP during the study period, compared with 265 men who presented for sperm cryopreservation from 2005 to 2020. The median time from referral to consultation was 4 days (IQR=2-7). Fifty-five men (94.8%) attempted sperm cryopreservation, and 49 (84.5%) successfully preserved sperm. Conclusion: Since the establishment of a public FP programme for cancer patients, there has been an increase in the demand for FP services at our centre. Regular review of FP services is warranted to assess changes in demand and identify areas for improvement. <br></p>-
dc.languageeng-
dc.publisherHong Kong Academy of Medicine-
dc.relation.ispartofHong Kong Medical Journal-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titlePublic fertility preservation programme for cancer patients in Hong Kong-
dc.typeArticle-
dc.identifier.doi10.12809/hkmj2311060-
dc.identifier.scopuseid_2-s2.0-85214319664-
dc.identifier.volume30-
dc.identifier.issue6-
dc.identifier.spage452-
dc.identifier.epage460-
dc.identifier.eissn2226-8707-
dc.identifier.issnl1024-2708-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats